Design of Experiment and Statistical Analysis in Dermatology and Aesthetic Trials

This white paper explores best practices for designing and analyzing dermatology and aesthetic clinical trials, with a strong focus on time-to-healing as a critical endpoint. It details how clear endpoint definitions, thoughtful trial designs, and advanced statistical methods ensure credible and meaningful results. Beyond healing speed, it highlights the importance of holistic outcome measures like patient satisfaction, cosmetic quality, and safety. This paper provides insights into how Symbio leverages methodological expertise to generate robust, patient-centered evidence that supports regulatory approval, market adoption, and better patient outcomes.